Tag: ziprasidone
Letter to the Editor: A case of Paranoid Schizophrenia and severe antipsychotic-induced Parkinson’s Disorder treated with a combination of olanzapine and lurasidone
Oleg V. Tcheremissine, MD, and Danielle Englert, MD Dr. Tcheremissine is Research Director, Department of Psychiatry and Behavioral Sciences, Carolinas Healthcare System; Dr. Englert is Director of Deep Brain Stimulation Program Center for Parkinson’s Disease and Movement Disorders, Department of Neurology Carolinas Healthcare System, Charlotte, North Carolina. Innov Clin Neurosci. 2013;10(9–10):10–14
A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report
by Gail T. Arcari, MEd; Asante K. Mendes, MD; and Robert B. Sothern, PhD Ms. Arcari is from Cromwell, Connecticut; Dr. Mendes is from Tufts University School of Medicine, Boston, Massachussetts, and University of Connecticut Health Center, Farmington, Connecticut; and Dr. Sothern is Research Assistant Professor, College of Biological Sciences, University of Minnesota, St. Paul, […]
Real-world Data on Atypical Antipsychotic Medication Side Effects
by Elisa Cascade; Amir H. Kalali, MD; Sagar Mehra; and Jonathan M. Meyer, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles, Inc., and Professor of Psychiatry, University of California, San Diego, California; Mr. Mehra is a student intern at iGuard, Falls […]
Recommendations for Pharmacological Management of Inpatient Aggression in Children and Adolescents
Parikshit Deshmukh, MD; Guarav Kulkarni, MD; and Drew Barzman, MD Dr. Deshmukh is a resident with the Division of Psychiatry, University Hospitals Case Medical Center, Cleveland, Ohio; Dr. Kulkarni is Research Assistant, Child and Adolescent Forensic Psychiatry Service, Division of Child and Adolescent Psychiatry, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; and Dr. Barzman is […]
Use of Intramuscular Ziprasidone for the Control of Acute Psychosis or Agitation in an Inpatient Geriatric Population: An Open-Label Study
by Alina R. Rais, MD; Kristi Williams, MD; Theodor Rais, MD; Tanvir Singh, MD; and Marijo Tamburrino, MD Dr. Alina Rais is Associate Professor, Director Psychogeriatric Program of the University of Toledo Medical Center (UTMC), Toledo, Ohio; Dr. Williams is Associate Professor, Director Psychiatry Residency Training Program UTMC, Toledo, Ohio; Dr. Theodor Rais is Associate […]
